Emodin Augments Cisplatin Cytotoxicity in Platinum-Resistant Ovarian Cancer Cells via ROS-Dependent MRP1 Downregulation

Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis

(2013) Krishnendu Sinha et al.   ARCHIVES OF TOXICOLOGY

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species

(2011) Yeong-In Yang et al.   GYNECOLOGIC ONCOLOGY

Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: The mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1

(2010) Xin-zhi Huang et al.   CANCER BIOLOGY & THERAPY

Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulation

(2009) Wei Wang et al.   BIOCHEMICAL PHARMACOLOGY

Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin

(2009) Giovanni Luca Beretta et al.   BIOCHEMICAL PHARMACOLOGY

First-line treatment of advanced ovarian cancer: current research and perspectives

(2009) Claudia Marchetti et al.   Expert Review of Anticancer Therapy

New therapies for ovarian cancer: Cytotoxics and molecularly targeted agents

(2008) Phuong Dinh et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Emodin-Induced Generation of Reactive Oxygen Species Inhibits RhoA Activation to Sensitize Gastric Carcinoma Cells to Anoikis

(2008) Jun Cai et al.   NEOPLASIA